[Clinical analysis of laparoscopic remedial surgery for endoscopic lesions in early colorectal cancer].

医学 结直肠癌 外科 腹腔镜手术 癌症 淋巴结 转移 切除缘 解剖(医学) 腹腔镜检查 内科学 切除术
作者
Jingyao Zhang,Qiang Feng,Guiqi Wang,Xishan Wang,Zhaoxu Zheng,Yi Wang,Dongkui Xu
出处
期刊:PubMed 卷期号:41 (11): 870-872
标识
DOI:10.3760/cma.j.issn.0253-3766.2019.11.013
摘要

Objective: To investigate the safety and feasibility of laparoscopic remedial surgery in patients who didn't reach the cure criterion of early colorectal cancer after endoscopic resection. Methods: The clinical and follow-up data of 12 patients who didn't reach the cure criterion of early colorectal cancer and then underwent endoscopic resection was collected. The clinicalpathological features and remedial indications were analyzed to evaluate the effects of laparoscopic remedial surgery. Results: The average number of lymph nodes in the lymph node dissection was 15 during remedial surgery, and 3 of them had lymph node metastasis. Among the 3 patients with residual cancer, two cases were poorly differentiated, 1 case was moderately differentiated, 1 case was positive for basal margin, and 1 case had vascular invasion. No lymph node metastasis occurred in the 9 patients who had no residual cancer. Among these, 8 cases were moderately differentiated, 1 case was poorly differentiated and 2 cases had positive basal margin. The average follow-up duration was 40 months and all 12 patients were in a state of survival at the last follow-up. During the follow-up of the 3 patients with residual cancer, 1 patient received adjuvant chemotherapy with unknown prognosis; 1 patient received postoperative adjuvant radiochemotherapy, and lung metastasis occurred; 1 patient did not receive any treatment after surgery and survived for 33 months. Conclusions: Laparoscopic remedial surgery is a safe and feasible remedy for patients who didn't reach the cure criterion of early colorectal cancer after endoscopic resection. However, the choice of remedial strategy for colorectal carcinoma needs further investigation for patients with no vascular invasion, high degree of differentiation, and negative basal margin.目的: 探讨早期结直肠癌患者内镜下病损切除后未达治愈标准的补救方式,以及行腹腔镜补救手术的安全性和可行性。 方法: 收集12例早期结直肠癌内镜下病损切除治疗后未达治愈标准再行腹腔镜补救手术患者的临床和随访资料,分析其临床病理特征和补救手术指征,评价腹腔镜补救手术的效果。 结果: 12例患者腹腔镜补救手术平均清扫淋巴结15枚。其中3例术后病理显示有癌残留,且均发生淋巴结转移;2例为低分化,1例为中分化;1例基底切缘阳性;1例发生脉管侵犯。9例未发生癌残留的患者无淋巴结转移;8例为中分化,1例为低分化;2例基底切缘阳性。平均随访40个月,12例患者末次随访时均生存。3例腹腔镜补救手术后病理显示癌残留的患者中,1例术后辅助化疗,预后不详;1例术后辅助放化疗,发生肺转移;1例术后未接受其他治疗,生存33个月。 结论: 腹腔镜补救手术是内镜下病损切除后未达治愈标准结直肠癌患者安全可行的补救方式,但对于无脉管侵犯、肿瘤分化程度较高和基底切缘阴性的结直肠癌患者,补救策略的选择有待进一步探究。.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
寒冷的断缘完成签到,获得积分10
2秒前
医无止境完成签到,获得积分10
3秒前
完美梨愁完成签到 ,获得积分10
3秒前
Keyuuu30完成签到,获得积分10
4秒前
嘿嘿完成签到 ,获得积分10
5秒前
chenkj完成签到,获得积分10
5秒前
EricSai完成签到,获得积分10
5秒前
ikun完成签到,获得积分10
5秒前
丰知然应助amanda采纳,获得10
7秒前
我爱螺蛳粉完成签到 ,获得积分10
7秒前
材1完成签到 ,获得积分10
8秒前
ArkZ完成签到 ,获得积分10
9秒前
从今伴君行完成签到,获得积分10
10秒前
顺利兰完成签到 ,获得积分10
11秒前
imbecile完成签到 ,获得积分10
11秒前
桂花完成签到 ,获得积分10
12秒前
梅花易数完成签到,获得积分10
15秒前
丰知然应助amanda采纳,获得10
15秒前
yuchen完成签到,获得积分10
15秒前
小机灵鬼完成签到 ,获得积分10
16秒前
简单绯完成签到,获得积分10
16秒前
const完成签到,获得积分10
19秒前
sdfdzhang完成签到 ,获得积分10
19秒前
祭途完成签到,获得积分10
24秒前
tutu完成签到 ,获得积分10
25秒前
体贴的叛逆者完成签到,获得积分10
26秒前
烟酒不离生完成签到 ,获得积分10
26秒前
LilyChen完成签到 ,获得积分10
26秒前
panda完成签到,获得积分0
27秒前
339564965完成签到,获得积分10
30秒前
byby完成签到,获得积分10
30秒前
虚拟的尔蓝完成签到 ,获得积分10
31秒前
ccc完成签到,获得积分10
31秒前
阡陌完成签到,获得积分10
32秒前
Agnesma完成签到,获得积分10
33秒前
扶我起来写论文完成签到 ,获得积分10
34秒前
研友_nPxRRn完成签到,获得积分10
35秒前
研友_Lmg1gZ完成签到,获得积分0
36秒前
张张张xxx完成签到,获得积分10
36秒前
酷波er应助dablack采纳,获得20
37秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Effect of reactor temperature on FCC yield 2000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
Mission to Mao: Us Intelligence and the Chinese Communists in World War II 600
MATLAB在传热学例题中的应用 500
Geochemistry, 2nd Edition 地球化学经典教科书第二版,不要epub版本 431
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3303336
求助须知:如何正确求助?哪些是违规求助? 2937632
关于积分的说明 8482754
捐赠科研通 2611585
什么是DOI,文献DOI怎么找? 1426065
科研通“疑难数据库(出版商)”最低求助积分说明 662535
邀请新用户注册赠送积分活动 647026